However, no assurance can be given that any of these Warrants will be exercised. Volition expects to use the net proceeds of the offering for research and continued product development ...

StockNews.com initiated coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the stock. VNRX has been the subject of ...

Geode Capital Management LLC boosted its stake in shares of VolitionRx Limited (NYSE:VNRX – Free Report) by 15.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 730,448 shares of the ...

Volition to participate in the upcoming 14 th Annual LifeSci Partners Corporate Access Event on January 15 th, 2025 at the Beacon Grand Hotel in San Francisco. HENDERSON, Nev., Dec. 12, 2024 ...

And with that, I'll turn the call over to Tom. Tom Butera: Thanks, Lou. Thank you everyone for joining Volition's Third Quarter 2024 Earnings Call today. As Cameron always says, we appreciate your ...

Morningstar brands and products Company Portfolio ...

Volition to participate in the upcoming 14th Annual LifeSci Partners Corporate Access Event on January 15th, 2025 at the Beacon Grand Hotel in San Francisco. HENDERSON, Nev., Dec. 12, 2024 /PRNewswire ...

However, no assurance can be given that any of these Warrants will be exercised. Volition expects to use the net proceeds of the offering for research and continued product development, clinical ...

Volition expects to use the net proceeds of the offering for research and continued product development, clinical studies, product commercialization, working capital and other general corporate ...